antimicrobi
peptid
essenti
compon
innat
immun
play
import
role
host
defenc
microbi
pathogen
receiv
increas
attent
recent
potenti
novel
pharmaceut
agent
meet
requir
necessari
basic
scienc
studi
clinic
trial
larg
quantiti
peptid
need
gener
isol
natur
sourc
chemic
synthesi
costeffect
rel
low
cost
easi
scaleup
recombin
approach
render
attract
mean
largescal
product
antimicrobi
peptid
among
mani
system
avail
protein
express
escherichia
coli
remain
wide
use
host
antimicrobi
peptid
produc
e
coli
often
express
fusion
protein
effect
mask
peptid
potenti
lethal
effect
toward
bacteri
host
protect
peptid
proteolyt
degrad
although
carrier
confer
peptid
solubl
other
promot
format
inclus
bodi
present
minireview
consid
commonli
use
carrier
protein
fusion
express
antimicrobi
peptid
e
coli
favour
properti
sumo
small
ubiquitinrel
modifi
novel
fusion
partner
also
discuss
antimicrobi
peptid
geneencod
peptid
antibiot
exhibit
bactericid
activ
divers
microb
present
virtual
everi
life
form
import
compon
innat
immun
system
broad
spectrum
activ
low
propens
resist
develop
peptid
recent
receiv
increas
attent
potenti
new
antiinfect
therapeut
better
understand
mechan
action
structurefunct
relationship
extens
biolog
structur
studi
need
perform
requir
suffici
amount
highli
purifi
peptid
moreov
peptid
eventu
develop
altern
antibiot
widespread
clinic
use
huge
amount
peptid
readili
avail
costeffect
manner
prepar
isol
natur
sourc
typic
complic
timeconsum
therefor
effici
way
obtain
peptid
larg
amount
besid
appli
design
peptid
alter
sequenc
chemic
synthesi
allow
product
natur
design
peptid
cost
prohibit
largescal
manufactur
gener
recombin
dna
technolog
provid
mean
econom
protein
product
inde
mani
antimicrobi
peptid
success
produc
recombin
express
variou
heterolog
host
addit
costeffect
recombin
approach
also
facilit
product
peptid
modifi
sequenc
allow
incorpor
isotop
structur
studi
escherichia
coli
yeast
two
major
system
use
produc
recombin
antimicrobi
peptid
togeth
account
report
case
number
antimicrobi
peptid
produc
yeast
good
yield
howev
sever
other
express
neglig
amount
obtain
inact
form
yeast
system
use
one
case
recombin
peptid
detect
even
though
gene
transcrib
overal
yeast
use
much
less
commonli
bacteria
recombin
product
antimicrobi
peptid
popular
e
coli
come
attract
featur
eg
fast
growth
rate
low
cost
simpl
fact
posttransl
modif
requir
li
calcul
base
data
collect
recombinantlyproduc
antimicrobi
peptid
databas
abbrevi
gabat
transaminas
ompasp
outermembraneproteina
signal
peptid
trp
tryptophanoperonencod
activ
antimicrobi
peptid
howev
certain
properti
antimicrobi
peptid
pose
difficulti
direct
express
e
coli
first
antibacteri
natur
make
potenti
fatal
produc
host
secondli
small
size
high
cation
content
make
highli
suscept
proteolyt
degrad
strategi
found
effect
overcom
barrier
express
peptid
fusion
peptid
interest
genet
attach
carrier
protein
fusion
partner
play
similar
role
natur
proseg
peptid
inact
precursor
form
protect
peptid
host
organ
peptid
biosynthesi
variou
protein
differ
size
properti
use
carrier
figur
wherea
facilit
solubl
express
other
promot
format
inclus
bodi
case
carrierpeptid
junction
usual
contain
enzymat
chemic
cleavag
site
enabl
target
peptid
releas
correspond
method
except
antimicrobi
peptid
produc
e
coli
nearli
express
fusion
protein
closer
look
peptid
express
nonfus
reveal
either
rel
larg
size
ie
residu
form
inclus
bodi
upon
express
may
allevi
potenti
problem
toxic
instabl
express
tandem
multim
view
special
type
fusion
accord
recombinantlyproduc
antimicrobi
peptid
databas
http
facultyistunomahaeduchen
rapd
thioredoxin
frequent
use
carrier
protein
account
report
fusion
express
antimicrobi
peptid
figur
thioredoxin
lowmolecularmass
protein
kda
highli
solubl
possess
chaperonelik
activ
properti
thioredoxin
wide
use
fusion
carrier
promot
solubl
express
recombin
proteinspeptid
e
coli
cytoplasm
summar
tabl
thioredoxinpeptid
fusion
inde
found
solubl
fraction
small
percentag
insolubl
express
could
result
unusu
design
eg
concatamer
intern
fusion
unoptim
paramet
noteworthi
lowtemperatur
induct
sometim
need
obtain
solubl
thioredoxin
fusion
peptid
easi
comparison
origin
valu
given
g
cell
recalcul
assumpt
bacteri
cultur
yield
g
wet
cell
b
avail
c
estim
base
amount
fusion
protein
contain
disulfid
bridg
special
host
strain
eg
origami
cell
novagen
madison
wi
usa
engin
promot
disulfid
bond
format
greatli
increas
chanc
obtain
solubl
fusion
proper
fold
glycerol
deterg
frequent
ad
cell
lysi
buffer
increas
yield
solubl
protein
antimicrobi
peptid
known
interact
bacteri
membran
agent
help
retriev
fusion
protein
entrap
membran
compon
cell
lysi
addit
gener
properti
fusion
carrier
thioredoxin
small
size
make
particularli
favour
peptid
product
allow
peptid
interest
constitut
rel
larg
percentag
fusion
recent
studi
show
among
differ
carrier
protein
test
thioredoxin
fusion
gave
highest
absolut
yield
fuse
peptid
even
though
fusion
overal
express
level
highest
actual
peptid
yield
vari
case
case
extrem
valu
found
end
tabl
exampl
yield
sever
much
higher
peptid
case
amount
fusion
protein
close
glitr
cultur
sinc
wet
cell
weight
given
difficult
judg
whether
high
yield
result
high
cell
densiti
high
express
level
novagen
seri
commonli
use
commerci
thioredoxin
fusion
vector
presenc
histag
histidin
tag
fusion
facilit
protein
purif
imac
immobil
metalaffin
chromatographi
addit
seri
contain
enterokinas
recognit
site
upstream
target
peptid
allow
peptid
liber
upon
enterokinas
cleavag
desir
howev
proteolyt
chemic
cleavag
site
gener
clone
stage
serv
purpos
wherea
chemic
cleavag
found
effici
releas
target
peptid
case
appli
enzymat
cleavag
found
poor
sever
case
gst
glutathion
transferas
anoth
commonli
use
carrier
protein
fusion
express
antimicrobi
peptid
figur
like
thioredoxin
gst
well
establish
carrier
solubl
express
fusion
protein
e
coli
gst
fusion
protein
quickli
purifi
crude
lysat
affin
chromatographi
immobil
glutathion
owe
easi
captur
mild
elut
condit
gst
fusion
routin
use
pulldown
assay
confirm
disprov
proteinprotein
interact
antimicrobialpeptid
express
gstpeptid
fusion
usual
found
solubl
portion
would
expect
tabl
although
sometim
product
solubl
fusion
may
achiev
optim
sever
factor
host
strain
growth
temperatur
reason
mention
paragraph
deterg
common
ingredi
cell
lysi
buffer
increas
tabl
antimicrobi
peptid
express
fusion
protein
purf
fragment
fusion
insolubl
size
shown
number
amino
acid
residu
abbrevi
use
magainin
analogu
magainin
famili
peptid
isol
skin
xenopu
laevi
south
african
claw
frog
pgq
antimicrobi
peptid
ntermin
glycin
g
ctermin
glutamin
q
isol
xenopu
laevi
stomach
three
valu
column
refer
yield
correspond
refer
column
size
fusion
solubl
commerci
gstfusion
plasmid
usual
contain
specif
proteas
recognit
site
cleavag
releas
desir
peptid
carrier
chemic
cleavag
rare
use
purpos
probabl
nonspecif
cleavag
carrier
substanti
complic
subsequ
purif
one
disadvantag
gst
carrier
peptid
product
rel
larg
size
kda
decreas
effici
system
peptid
interest
usual
small
thu
compris
modest
percentag
express
fusion
seen
tabl
highest
yield
report
mglitr
lower
averag
valu
given
system
gst
larg
size
also
make
fusion
highli
suscept
proteolyt
degrad
one
case
fusion
degrad
could
stop
ad
proteas
inhibitor
protein
purif
caus
failur
obtain
even
trace
amount
peptid
anoth
fail
case
uncontrol
degrad
also
suspect
reason
protein
fragment
contain
ntermin
amino
acid
purf
amidophosphoribosyltransferas
also
wide
use
carrier
antimicrobi
peptid
express
tabl
contrast
thioredoxin
gst
purf
fragment
strongli
enhanc
format
inclus
bodi
compar
solubl
fusion
insolubl
express
believ
abl
complet
mask
peptid
intrins
toxic
effect
better
protect
peptid
proteolyt
activ
inclus
bodi
contain
purf
fusion
collect
cell
lysat
centrifug
purif
inclus
bodi
simpl
wash
requir
sinc
fusion
protein
usual
repres
major
insolubl
compon
except
one
case
peptid
releas
furinmedi
cleavag
peptid
attach
purf
fragment
liber
hydroxylamin
treatment
fusion
solubil
denatur
buffer
reason
predomin
use
chemic
cleavag
probabl
due
denatur
condit
requir
fusion
purif
make
direct
enzymat
cleavag
impract
nearli
antimicrobi
peptid
express
purf
fusion
contain
disulfid
bond
thu
refold
gener
requir
restor
activ
three
case
list
tabl
peptid
yield
rel
high
two
protein
express
induc
attenu
suggest
high
yield
probabl
result
high
cell
densiti
anoth
case
total
protein
inclus
bodi
reach
glitr
cell
cultur
confirm
high
cell
densiti
cultiv
perform
sinc
volum
cultur
typic
yield
g
wet
cell
fusion
partner
special
design
target
peptid
inclus
bodi
includ
oxosteroid
ketosteroid
isomeras
tata
box
bind
proteinassoci
factor
kda
histon
fold
domain
encod
open
read
frame
pseudomona
aeruginosa
bacteriophag
baculovir
polyhedron
nine
peptid
collect
recombinantlyproduc
antimicrobi
peptid
databas
produc
use
inteinmedi
system
make
third
commonli
use
carrier
along
purf
fragment
intein
protein
counterpart
intron
excis
precursor
protein
rejoin
flank
region
inteinmedi
protein
splice
autocatalyt
event
requir
auxiliari
enzym
combin
affin
tag
intein
allow
effici
protein
purif
util
induc
selfcleav
capabl
exampl
one
terminu
fuse
chitinbind
domain
fuse
protein
interest
intein
fusion
captur
chitin
column
upon
induct
thiol
reagent
ph
temperatur
shift
target
protein
releas
inteinmedi
selfcleavag
intein
system
elimin
need
exogen
proteas
chemic
requir
fusion
system
remov
carrier
allow
target
protein
obtain
high
puriti
onestep
purif
employ
singl
column
thu
technolog
lower
product
cost
simplifi
protein
recoveri
commerci
intein
system
avail
new
england
biolab
beverli
usa
addit
initi
develop
system
use
engin
sce
vma
saccharomyc
cerevisia
vacuolar
atpas
subunit
intein
kda
carrier
base
ssp
synechocysti
sp
dnab
miniintein
kda
also
avail
system
yield
protein
nativ
sequenc
variou
biolog
import
peptid
includ
antimicrobi
peptid
tabl
antimicrobi
bioactiv
peptid
produc
inteinmedi
system
peptid
label
asterisk
antimicrobi
peptid
size
shown
number
amino
acid
residu
abbrevi
use
antibacteri
peptid
see
tabl
antimicrobiallik
protein
also
known
spermassoci
antigen
precursor
hbnp
human
brain
natriuret
peptid
hegf
human
epiderm
growth
factor
delet
mutant
maxadilan
vasodil
peptid
isol
sandfli
salivari
gland
rhpacap
recombin
human
pituitari
adenyl
cyclaseactiv
polypeptid
rmbay
peptid
design
imit
bay
vasoact
intestin
peptid
receptor
select
agonist
develop
bayer
corpor
rmrom
agonist
sheep
myeloid
antimicrobi
peptid
size
produc
laboratori
scale
use
system
tabl
order
inteinmedi
cleavag
effect
fusion
protein
solubl
correctli
fold
form
case
solubl
express
achiev
rel
low
growth
temperatur
eg
c
fusion
goe
inclus
bodi
refold
requir
prior
purif
highest
peptid
yield
tabl
name
mglitr
result
highdens
cultur
g
cell
litr
cultur
howev
even
without
case
averag
yield
nonantimicrobi
peptid
still
much
higher
antimicrobi
peptid
lower
yield
antimicrobi
peptid
could
due
uncontrol
autocleavag
releas
small
amount
peptid
neg
influenc
cell
proteinmak
machineri
prematur
cleavag
fusion
protein
express
intrins
problem
associ
intein
system
caus
loss
yield
target
protein
protein
antimicrobi
peptid
loss
due
vivo
cleavag
probabl
offset
gain
rel
simpli
purif
approach
long
uncontrol
cleavag
kept
low
level
allow
easi
comparison
origin
figur
given
mg
per
g
cell
recalcul
assumpt
bacteri
cultur
yield
g
wet
cell
method
still
give
better
yield
fusion
system
howev
antimicrobi
peptid
could
seriou
problem
certain
antimicrobi
peptid
known
inhibit
cellular
function
direct
interact
nucleic
acid
therefor
even
trace
amount
releas
peptid
fatal
host
recent
sumo
use
novel
fusion
carrier
product
recombin
protein
sumo
small
protein
consist
amino
acid
structur
relat
function
differ
ubiquitin
protein
hydrophob
core
hydrophil
surfac
therefor
highli
solubl
fusion
partner
sumo
found
improv
fold
solubl
target
protein
addit
exist
sumo
proteas
offer
uniqu
advantag
system
unlik
commonli
use
proteas
recogn
short
sequenc
motif
sumo
proteas
recogn
sumo
tertiari
structur
result
enzym
never
cleav
within
protein
interest
allow
product
target
protein
nativ
nterminu
fusion
properli
design
sever
difficulttoexpress
protein
includ
matrix
metalloproteas
sarscov
severeacuterespiratorysyndrom
coronaviru
protein
success
express
e
coli
use
sumo
fusion
strategi
system
also
appli
product
variou
bioactiv
peptid
tabl
sumo
small
size
kda
like
thioredoxin
allow
rel
high
peptidetocarri
ratio
favour
peptid
yield
yield
tabl
lie
within
rang
mglitr
cultur
reason
small
peptid
higher
averag
gst
fusion
although
applic
sumo
fusion
strategi
antimicrobi
peptid
wide
report
research
group
emori
univers
atlanta
ga
usa
recent
grant
patent
antimicrobi
peptid
product
use
system
author
patent
claim
variou
antimicrobi
peptid
includ
cramp
cathelicidinrel
antimicrobi
peptid
protein
whose
ntermin
sequenc
leuleu
cathelicidin
effici
produc
commerci
sumo
fusion
vector
obtain
lifesensor
malvern
pa
usa
invitrogen
carlsbad
ca
usa
vector
presenc
histag
nterminu
sumo
protein
sequenc
allow
rapid
purif
fusion
imac
fusion
express
necessari
effect
strategi
antimicrobialpeptid
product
e
coli
although
commonli
use
carrier
protein
promot
proper
fold
enhanc
solubl
fuse
peptid
certain
carrier
purf
fragment
special
design
promot
inclusionbodi
format
sinc
mani
antimicrobi
peptid
success
express
solubl
fusion
forc
fusion
protein
inclus
bodi
necessari
protect
bacteri
host
short
peptid
without
disulfid
linkag
refold
gener
requir
restor
activ
insolubl
express
advantag
easi
purif
howev
disulfidebondcontain
peptid
need
correctli
fold
order
show
activ
solubl
express
prefer
refold
timeconsum
may
guarante
high
recoveri
activ
thioredoxin
gst
two
well
establish
carrier
promot
solubl
express
fuse
protein
although
carrier
highli
effici
improv
solubl
growth
temperatur
celllin
optim
sometim
need
obtain
best
result
size
gst
twice
big
thioredoxin
drawback
yield
caus
unfavour
ratio
peptid
carrier
thioredoxin
gst
fusion
enterokinas
factor
xa
thrombin
routin
use
liber
peptid
howev
cleavag
enzym
sometim
found
ineffici
although
enzymat
cleavag
normal
effici
releas
target
protein
fusion
carrier
case
antimicrobi
peptid
found
less
effici
chemic
cleavag
possibl
reason
certain
antimicrobi
peptid
tend
form
oligom
block
cleavag
site
intein
system
elimin
need
proteas
chemic
reagent
carrier
remov
offer
great
benefit
target
protein
purif
howev
uninduc
selfcleavag
activ
may
limit
valu
antimicrobi
peptid
product
sumo
rel
new
fusion
carrier
system
sever
advantag
first
like
thioredoxin
gst
sumo
promot
solubl
express
fuse
protein
secondli
sumo
small
size
result
rel
high
mass
ratio
target
protein
thirdli
sumo
proteas
highli
specif
effici
remov
carrier
gener
target
protein
nativ
nterminu
properti
benefit
product
type
protein
second
third
advantag
especi
relev
antimicrobi
peptid
size
antimicrobi
peptid
small
therefor
higher
stoichiometr
ratio
dramat
increas
net
yield
mention
commonli
use
proteas
sometim
ineffici
releas
target
peptid
exampl
express
thioredoxin
gst
fusion
human
antimicrobi
peptid
effici
releas
thrombin
factor
xa
cleavag
recent
bommariu
et
al
report
product
use
sumo
system
howev
detail
inform
cleavag
effici
peptid
yield
provid
would
interest
know
whether
sumo
proteas
uniqu
properti
allow
overcom
steric
hindranc
impos
antimicrobi
peptid
oligomer
although
sumo
fusion
system
wide
use
recombin
product
antimicrobi
peptid
certainli
offer
attract
altern
besid
toxic
issu
technic
challeng
high
cost
manufactur
peptid
anoth
obstacl
wide
applic
antimicrobi
peptid
typic
cost
peptid
rang
per
gram
much
higher
convent
antibiot
fusion
express
bacteria
far
success
approach
among
mani
other
made
reduc
cost
howev
current
cost
though
lower
chemic
synthesi
remain
high
commerci
accept
one
factor
limit
success
fusion
express
might
lack
carrier
specif
design
peptid
current
system
review
articl
gener
purpos
recombin
protein
product
regard
tandem
repeat
special
type
fusion
except
howev
protein
express
level
tandem
design
usual
proport
degre
multimer
necessarili
guarante
better
peptid
yield
normal
fusion
vassilevski
et
al
recent
suggest
mani
short
modul
helper
function
await
discoveri
thu
novel
system
base
modul
special
peptid
combin
optim
express
andor
cultiv
eg
new
cell
line
high
cell
densiti
cultiv
may
move
yield
next
level
futur
